Add BrightSurf on Google Email

Researchers conduct first-ever study to characterize microbiota in saliva of weaned piglets on commercial farms in Brazil

Researchers characterized the microbial composition of oral fluid, feces, and environment of nursery piglets on commercial farms in Brazil. The study found distinct oral fluid bacterial profiles differing from those in feces and environment, with potential implications for swine health and production.

Who should receive preventive treatment for TB? Individuals of all ages with positive skin or blood test, new study says

A new study suggests that countries should prioritize tuberculosis treatment for exposed individuals with evidence of TB infection, regardless of age—except in high-burden settings, where all exposed individuals should be considered for treatment. Preventive treatment can stop latent TB infections from developing into deadly TB disease.

SourceBoston University School of Public Health·JournalThe Lancet Respiratory Medicine·TypeSystematic review·DateMay 8, 2024

Key role found for gut epithelial cells and their expression of MHCII in the defense against deadly diarrheal infections

Researchers have identified a subset of intestinal epithelial cells that act as both the major target and responder in a mouse model of gut infection by Citrobacter rodentium. These cells, known as distal colonocytes, trigger a unique gene-expression program when infected with the bacteria.

SourceUniversity of Alabama at Birmingham·JournalNature·TypeExperimental study·DateMay 6, 2024

Medical school scientist creates therapy to kill hypervirulent bacteria

A new therapy has been identified that can penetrate the slime protecting drug-resistant bacteria, allowing it to be killed by the body's immune system or antibiotics. The antimicrobial peptide, derived from cow peptides, targets sugar connections in the slime structure, damaging its integrity and allowing entry.

SourceUniversity of Central Florida·JournalCell Reports Physical Science·TypeExperimental study·DateMay 1, 2024

Treatment for deadly superbug C. diff may be weakening

Clinical trials show decreased effectiveness of vancomycin in treating C. diff infection, with reduced cure rates and lower sustained clinical responses associated with antimicrobial resistance. The finding poses a significant concern for the management of C. diff infection, with only two recommended antibiotics available.

SourceUniversity of Houston·JournalClinical Infectious Diseases·DateApr 25, 2024

German study finds antibiotic use in patients hospitalised with COVID-19 appears to have no beneficial effect on clinical outcomes

A German study of over 1,300 hospitalised adults with moderate COVID-19 found that antibiotic treatment was associated with a five times greater likelihood of clinical deterioration. The researchers highlight the need for improved antibiotic stewardship interventions and rational use of antibiotics during viral pandemics.

Black women hospitalised in USA with blood infection resistant to last-resort antibiotic at increased risk of death

A recent study published at the ESCIMD Global Congress found that Black female patients are at higher risk of death from carbapenem-resistant enterobacterales (CRE) bloodstream infections. The study analyzed data from 362 US hospital patients and discovered that Black females had a significantly increased risk of mortality compared to ...

Bringing multidrug-resistant pathogens to their knees

Researchers have developed novel antibiotics based on protein building blocks with fluorous lipid chains to fight resistant pathogens. The compounds were shown to be effective against methicillin-resistant Staphylococcus aureus (MRSA) in mouse models, killing bacteria without developing resistance.

SourceWiley·JournalAngewandte Chemie International Edition·TypeExperimental study·DateApr 8, 2024

Attack and defence in the microverse

Researchers discovered that tiny RNA molecules play a decisive role in the complex interaction of attack and defence strategies when bacteria are infected with bacteriophages. The study found that these RNA molecules regulate phage genes as well as host genes, effectively explaining the destruction of bacterial cells.

SourceFriedrich-Schiller-Universitaet Jena·JournalCell Host & Microbe·TypeExperimental study·DateApr 4, 2024

Novel pre-clinical models help advance therapeutic development for antibiotic-resistant bacterial infections in Asian phenotypes

Researchers developed novel pre-clinical models to examine the behavior of Klebsiella pneumoniae (Kp) strains, revealing differences in aggressiveness between hospital-acquired and community-acquired infections. These models provide a platform for assessing novel drugs and interventions to combat Kp-related diseases.

Is active screening for tuberculosis among vulnerable populations cost-effective?

A systematic review by Gogichadze et al. suggests that active pulmonary TB screening programs targeting vulnerable populations in low-TB-incidence countries are cost-effective. The authors conclude that screening immigrants and other high-risk groups is a viable approach to detecting latent infections.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeSystematic review·DateMar 22, 2024

Study finds that for each 10% increase of certain bacteria type in the gut microbiome, the risk of hospitalisation for infections falls by up to a quarter

A study of two large European patient cohorts found that increased abundance of butyrate-producing gut bacteria is associated with reduced risk of hospitalization for infections. Each 10% increase in these bacteria resulted in a 14-25% lower risk of hospitalization, regardless of demographics or comorbidities.

Researchers led by NTU Singapore and the University of Toulouse discover how our body's immune response to bacterial infections could be ‘hurting’ us

Researchers from NTU Singapore and the University of Toulouse discovered a link between ionophores, cellular ion balance, and inflammation. The study found that cells trigger an immune response when potassium ions fall below a certain level, releasing pro-inflammatory molecules.

SourceNanyang Technological University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 19, 2024

Infections from these bacteria are on the rise. New blood test cuts diagnosis time from months to hours

Tulane University researchers have developed a CRISPR-based platform for diagnosing nontuberculous mycobacteria (NTM) infections, allowing for accurate results in as little as two hours. The blood test can identify over 93% of patients with an NTM infection, enabling rapid treatment plans and reducing the risk of complications.

SourceTulane University·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMar 14, 2024

Age and sex associated with patient’s likelihood of antimicrobial resistance

A new study published in PLOS Medicine found distinct patterns of antimicrobial resistance prevalence by age and sex across Europe. The study analyzed data from nearly one million people in 29 European countries, revealing that peaks in resistance varied by bacterial species and often occurred at the youngest and oldest ages.

SourcePLOS·JournalPLOS Medicine·TypeObservational study·DateMar 14, 2024

Steroid drugs used for HRT can combat E. coli and MRSA

Researchers from the University of Kent have identified steroid drugs used for hormone replacement therapy that can stop the growth of antibiotic-resistant E. coli and effectively kill MRSA. These findings suggest an alternative to conventional antibiotics, providing a potential solution to the growing threat of antibiotic resistance.

SourceUniversity of Kent·JournalThe Journal of Infectious Diseases·TypeComputational simulation/modeling·DateMar 13, 2024

Revolutionary chronic wound treatment could help millions

A team of international scientists has developed an effective treatment for preventing infection in chronic wounds that does not involve antibiotics. The new method involves the plasma activation of hydrogel dressings, producing a unique mix of chemical oxidants that are effective in decontaminating and aiding healing.

SourceUniversity of Sheffield·JournalAdvanced Functional Materials·TypeObservational study·DateMar 13, 2024

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

A new study finds that the high burden of typhoid fever in sub-Saharan African countries calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines. The study estimates that there are 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths.

SourceInternational Vaccine Institute·JournalThe Lancet Global Health·TypeObservational study·DateMar 12, 2024

Tuberculosis bacteria also present in 90% of those with symptoms, who are not diagnosed with TB

A study by Amsterdam UMC and University of Cape Town found that Mycobacterium tuberculosis is present in the respiratory aerosol of 90% of suspected TB patients, including those with negative sputum tests. This raises concerns about unknowingly transmitting infection and highlights the complexity of TB transmission.

SourceAmsterdam University Medical Center·JournalProceedings of the National Academy of Sciences·TypeRandomized controlled/clinical trial·DateMar 11, 2024

What makes a pathogen antibiotic-resistant?

A new study published in npj Antimicrobials and Resistance found that pathogenic bacteria E. coli and A. baumannii employ shared and unique mechanisms to acquire resistance to antibiotics ciprofloxacin and GP6. The researchers developed a method to track the acquisition of drug resistance using whole genome sequencing, which revealed t...

SourceSanford Burnham Prebys·Journalnpj Antimicrobials and Resistance·TypeExperimental study·DateMar 7, 2024

An overgrowth of nerve cells appears to cause lingering symptoms after recurrent UTIs

A study by Duke University researchers found that an overgrowth of nerve cells in the bladder may be responsible for persistent pain and urinary frequency after recurrent UTIs. The team identified a potential new treatment strategy by targeting mast cells, which release chemicals that drive nerve growth factor and increase sensitivity.

SourceDuke University Medical Center·JournalScience Immunology·DateMar 1, 2024

Zinc discovery holds promise for people with cystic fibrosis

Researchers at University of Queensland have discovered a zinc pathway defect in immune cells of people with cystic fibrosis, leading to increased susceptibility to bacterial infections. The team identified a potential solution by restoring the macrophages' ability to kill bacteria with a zinc transport protein.

SourceUniversity of Queensland·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateFeb 22, 2024